From design to action: participatory approach to capacity building needs for local overdose response plans.

Capacity-building Co-design workshop Opioid crisis Overdose Participatory design Public health

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
27 04 2023
Historique:
received: 26 04 2022
accepted: 09 03 2023
medline: 28 4 2023
pubmed: 27 4 2023
entrez: 26 4 2023
Statut: epublish

Résumé

In response to the rise in opioid-related deaths, communities across Ontario have developed opioid or overdose response plans to address issues at the local level. Public Health Ontario (PHO) leads the Community Opioid / Overdose Capacity Building (COM-CAP) project, which aims to reduce overdose-related harms at the community level by working with communities to identify, develop, and evaluate capacity building supports for local needs around overdose planning. The 'From Design to Action' co-design workshop used a participatory design approach to engage communities in identifying the requirements for capacity building support. A participatory approach (co-design) provided opportunity for collaborative discussion around capacity building needs at the community level. The co-design workshop included three structured collaborative activities to 1) prioritize scenarios that illustrated various challenges associated with community overdose response planning, 2) prioritize the challenges within each scenario and 3) prioritize the supports to address each of these challenges. It was conducted with fifty-two participants involved in opioid/overdose-related response plans in Ontario. Participatory materials were informed by the results of a situational assessment (SA) data gathering process, including survey, interview, and focus group data. A voting system, including dot stickers and discussion notes, was applied to identify priority supports and delivery mechanisms. At the workshop, key challenges and top-priority supports were identified, for development and implementation. The prioritized challenges were organized into five categories of capacity building supports addressing: 1) stigma & equity; 2) trust-based relationships, consensus building & on-going communication; 3) knowledge development & on-going access to information and data; 4) tailored strategies and plan adaptation to changing structures and local context; and 5) structural enablers and responsive governance. Using a participatory approach, the workshop provided an opportunity for sharing, generating, and mobilizing knowledge to address research-practice gaps at the community level for opioid response planning. The application of health design methods such as the 'From Design to Action' co-design workshop supports teams to gain a deeper understanding of needs for capacity building as well as illustrating the application of participatory approaches in identifying capacity building needs for complex public health issues such as the overdose crisis.

Sections du résumé

BACKGROUND
In response to the rise in opioid-related deaths, communities across Ontario have developed opioid or overdose response plans to address issues at the local level. Public Health Ontario (PHO) leads the Community Opioid / Overdose Capacity Building (COM-CAP) project, which aims to reduce overdose-related harms at the community level by working with communities to identify, develop, and evaluate capacity building supports for local needs around overdose planning. The 'From Design to Action' co-design workshop used a participatory design approach to engage communities in identifying the requirements for capacity building support.
METHODS
A participatory approach (co-design) provided opportunity for collaborative discussion around capacity building needs at the community level. The co-design workshop included three structured collaborative activities to 1) prioritize scenarios that illustrated various challenges associated with community overdose response planning, 2) prioritize the challenges within each scenario and 3) prioritize the supports to address each of these challenges. It was conducted with fifty-two participants involved in opioid/overdose-related response plans in Ontario. Participatory materials were informed by the results of a situational assessment (SA) data gathering process, including survey, interview, and focus group data. A voting system, including dot stickers and discussion notes, was applied to identify priority supports and delivery mechanisms.
RESULTS
At the workshop, key challenges and top-priority supports were identified, for development and implementation. The prioritized challenges were organized into five categories of capacity building supports addressing: 1) stigma & equity; 2) trust-based relationships, consensus building & on-going communication; 3) knowledge development & on-going access to information and data; 4) tailored strategies and plan adaptation to changing structures and local context; and 5) structural enablers and responsive governance.
CONCLUSION
Using a participatory approach, the workshop provided an opportunity for sharing, generating, and mobilizing knowledge to address research-practice gaps at the community level for opioid response planning. The application of health design methods such as the 'From Design to Action' co-design workshop supports teams to gain a deeper understanding of needs for capacity building as well as illustrating the application of participatory approaches in identifying capacity building needs for complex public health issues such as the overdose crisis.

Identifiants

pubmed: 37101181
doi: 10.1186/s12889-023-15414-3
pii: 10.1186/s12889-023-15414-3
pmc: PMC10132919
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

774

Informations de copyright

© 2023. The Author(s).

Références

Health Res Policy Syst. 2020 May 7;18(1):43
pubmed: 32380998
BMC Public Health. 2022 Jul 19;22(1):1390
pubmed: 35854231
BMC Health Serv Res. 2016 Oct 4;16(1):546
pubmed: 27716188
BMC Health Serv Res. 2018 Jul 25;18(1):585
pubmed: 30045726
BMC Med. 2018 Jun 20;16(1):95
pubmed: 29921272
BMJ Open. 2019 Sep 12;9(9):e028583
pubmed: 31515417
J Med Internet Res. 2017 May 18;19(5):e161
pubmed: 28526663
Front Psychiatry. 2022 Apr 22;13:867460
pubmed: 35530032
Milbank Q. 2016 Jun;94(2):392-429
pubmed: 27265562
Int J Nurs Stud. 2017 Mar;68:83-94
pubmed: 28095347
Harm Reduct J. 2019 Jun 10;16(1):37
pubmed: 31182099
BMC Public Health. 2018 Jun 1;18(1):684
pubmed: 29859075

Auteurs

Maryam Mallakin (M)

Health Design Studio, OCAD University, Toronto, ON, M5T 1W1, Canada.

Christina Dery (C)

Health Design Studio, OCAD University, Toronto, ON, M5T 1W1, Canada.

Yordanos Woldemariam (Y)

Health Design Studio, OCAD University, Toronto, ON, M5T 1W1, Canada.

Michael Hamilton (M)

Institute for Safe Medication Practices Canada (ISMP Canada), Toronto, ON, M2N6K8, Canada.

Kim Corace (K)

Royal Ottawa Mental Health Center, Ottawa, ON, K1Z7K4, Canada.
University of Ottawa, Ottawa, ON, K1N6N5, Canada.

Bernie Pauly (B)

University of Victoria, Victoria, BC, V8P5C2, Canada.
Canadian Institute for Substance Use Research, Vancouver, BC, V6Z2A9, Canada.

Triti Khorasheh (T)

Health Promotion, Chronic Disease and Injury Prevention, Public Health Ontario, Toronto, ON, M5G1V2, Canada.

Caroline Bennett AbuAyyash (CB)

Health Promotion, Chronic Disease and Injury Prevention, Public Health Ontario, Toronto, ON, M5G1V2, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, M5T3M7, Canada.

Pamela Leece (P)

Health Promotion, Chronic Disease and Injury Prevention, Public Health Ontario, Toronto, ON, M5G1V2, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, M5T3M7, Canada.
Department of Family and Community Medicine, University of Toronto, Toronto, ON, M5G1V7, Canada.

Katherine Sellen (K)

Health Design Studio, OCAD University, Toronto, ON, M5T 1W1, Canada. ksellen@faculty.ocadu.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH